The future is solid. Explore a full spectrum of possibilities with Imbucanna. Custom formulations. Contract Manufacturing. Patent pending intermediates. Not until our founding has any other company focused exclusively on producing highly concentrated cannabis powders that are compressible into tablets. Long processing times, extensive use of excipients, use of dangerous solvents, and other destructive causes have made tablets and other Oral Solid Dosage (OSD) forms of CBD nearly impossible to manufacture. Imbucanna is a B2B cannabis intermediates company that specializes in developing, producing, and marketing highly concentrated directly compressible cannabis powders to bridge this gap. Our patent-pending granulates allow even the smallest of manufacturers to easily scoop, fill, and compress an array of solid oral dose CBD and other cannabinoid products with tremendous ease.
| Website | https://imbucanna.com |
| Employees | 4 (2 on RocketReach) |
| Founded | 2019 |
| Address | 1807 Murray Rd SW Unit P, Roanoke, Virginia 24018, US |
| Phone | +1 540-597-2154 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Cbd, Hemp, Cannabis, Contract Manufacturing, Pharmaceutical Ingredients, Nutraceuticals, Cosmetics, Manufacturing, White Label, Private Label, Bulk Cbd, Bulk Hemp, Extraction, Processing, Formulation, Research And Development, Patent Pending, Intermediates, Ingredients |
| Competitors | Charlotte's Web, Joy Organics, Green Roads, Medterra, CBDistillery, cbdMD, Lazarus Naturals, Pure Spectrum, Elixinol, Endoca +24 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Imbucanna employee's phone or email?
Leo Mendez is the CEO of Imbucanna.
2 people are employed at Imbucanna.
Imbucanna is based in Roanoke, Virginia.
The NAICS codes for Imbucanna are [3254, 32, 32541, 325].
The SIC codes for Imbucanna are [283, 28].